Provided by Tiger Trade Technology Pte. Ltd.

Tscan Therapeutics, Inc.

1.04
+0.01000.97%
Volume:344.65K
Turnover:360.34K
Market Cap:59.02M
PE:-1.04
High:1.06
Open:1.03
Low:1.03
Close:1.03
52wk High:2.57
52wk Low:0.8824
Shares:56.75M
Float Shares:44.03M
Volume Ratio:0.63
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0000
EPS(LYR):-1.0000
ROE:-71.28%
ROA:-27.88%
PB:0.48
PE(LYR):-1.04

Loading ...

Jun 16, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 16, 2023

Major Issues Report

Form 8-K - Current report
Jun 12, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 06, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 05, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 31, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Major Issues Report

Form 8-K - Current report
May 26, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Correspondence

Form CORRESP - Correspondence
May 15, 2023

Correspondence

Form CORRESP - Correspondence
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2023

Major Issues Report

8-K - Current report
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Apr 10, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report